Evidence map›Paper›PMID 25541422›Full record

ArticleNeurobiology of aging2015

Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3.

Federico Scala, Salvatore Fusco, Cristian Ripoli, Roberto Piacentini, Domenica Donatella Li Puma, Matteo Spinelli, Fernanda Laezza, Claudio Grassi, Marcello D'Ascenzo

Registry-linked trialAbstract read
In one paragraph

Article in Neurobiology of aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07732933 (GSK-3 as a Target for Lithium-charged Au Nanoparticles in Bipolar Disorder), which is not on this map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07732933 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

GSK-3 as a Target for Lithium-charged Au Nanoparticles in Bipolar Disorder

TypeinterventionalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2026 to 2029Enrolled20ConditionsBipolar Disorder (BD), Bipolar Disorder (BPD)ArmsPeripheral blood sampling for PBMC isolation
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Amyloid β-dependent neuronal silencing through synaptic decoupling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Amyloid-β Effects on Peripheral Nerve: A New Model System.International journal of molecular sciences · 2023
    Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Federico ScalaInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy.
Salvatore FuscoInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy.
Cristian RipoliInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy.
Roberto PiacentiniInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy.
Domenica Donatella Li PumaInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy.
Matteo SpinelliInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy.
Fernanda LaezzaDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
Claudio GrassiInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy. Electronic address: grassi@rm.unicatt.it.
Marcello D'AscenzoInstitute of Human Physiology, Medical School, Università Cattolica, Rome, Italy. Electronic address: dascenzo@rm.unicatt.it.
Università Cattolica del Sacro Cuore · ITThe University of Texas Medical Branch at Galveston · US

Funding

UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Validation of FGF14 as a New Molecular Target of GSK3R01MH095995 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2012 to 2016
$1.9M
NCATS NIH HHS UL1 TR000071NCATS NIH HHS UL1TR000071NIMH NIH HHS R01 MH095995
6 · The paper itself

Abstract

Amyloid β-protein (Aβ) pathologies have been linked to dysfunction of excitability in neurons of the hippocampal circuit, but the molecular mechanisms underlying this process are still poorly understood. Here, we applied whole-cell patch-clamp electrophysiology to primary hippocampal neurons and show that intracellular Aβ42 delivery leads to increased spike discharge and action potential broadening through downregulation of A-type K(+) currents. Pharmacologic studies showed that caspases and glycogen synthase kinase 3 (GSK-3) activation are required for these Aβ42-induced effects. Extracellular perfusion and subsequent internalization of Aβ42 increase spike discharge and promote GSK-3-dependent phosphorylation of the Kv4.2 α-subunit, a molecular determinant of A-type K(+) currents, at Ser-616. In acute hippocampal slices derived from an adult triple-transgenic Alzheimer's mouse model, characterized by endogenous intracellular accumulation of Aβ42, CA1 pyramidal neurons exhibit hyperexcitability accompanied by increased phosphorylation of Kv4.2 at Ser-616. Collectively, these data suggest that intraneuronal Aβ42 accumulation leads to an intracellular cascade culminating into caspases activation and GSK-3-dependent phosphorylation of Kv4.2 channels. These findings provide new insights into the toxic mechanisms triggered by intracellular Aβ42 and offer potentially new therapeutic targets for Alzheimer's disease treatment.

Indexed as

Action PotentialsAlzheimer DiseaseAmyloid beta-PeptidesAnimalsCaspasesCells, CulturedDisease Models, AnimalElectrophysiological PhenomenaGlycogen Synthase Kinase 3HippocampusIn Vitro TechniquesMice, Inbred C57BLMice, TransgenicMolecular Targeted TherapyNeuronsPeptide FragmentsAmyloid beta-Peptidesamyloid beta-protein (1-42)CaspasesGlycogen Synthase Kinase 3Peptide FragmentsShal Potassium ChannelsAlzheimer's diseaseAmyloid-β proteinA-type K(+) currentCaspaseGSK-3Hippocampal neuronsIntrinsic excitabilityKV4.2

Identifiers

PMID25541422
PMCPMC4801354
OpenAlexW2029371901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.